BEVERLY HILLS, Calif.--(BUSINESS WIRE)--April 16, 2004--Vencor International, Inc. (Pink Sheets:VNCO) announced that it is expanding its newly developed relationship with Home Access Health Corporation, Hoffman Estates, Ill., by entering into a Memorandum of Understanding to develop international channels of distribution for HOME ACCESS(R) FDA approved at-home tests for HIV-1, HCV and other conditions to Mexico, South America, and Asia.
Home Access Health Corporation makes the only U.S. Food and Drug Administration (FDA) approved HIV-1 at-home test system. Home Access Health offers a simple at-home collection method combined with an accurate laboratory testing method that insures that clients receive accurate and reliable test results quickly, conveniently and confidentially. Test results and counseling are completely anonymous.
Further to this agreement Vencor and Home Access Health have agreed that they will collaborate on a "pilot" program in Mexico using existing infrastructure and sell HOME ACCESS(R) FDA approved at-home tests via the Internet and other appropriate venues to build the business at low risk/cost. Under the collaboration Home Access Health will provide FDA approved testing products and services, patient education and counseling via its existing English/Spanish language call center and laboratory systems from its headquarters in Hoffman Estates, Ill. Vencor will perform the sales, marketing, business development and product distribution and fulfillment in Mexico coordinated from its headquarters in Beverly Hills, Calif. Vencor management has already initiated in depth business development activities addressing logistics, product delivery, specimen handling, website development and sales, marketing and advertising activities that address the Spanish language market in Mexico.
Vencor will soon be offering the Home Access Health FDA approved HIV, Hepatitis C, Instant Cholesterol and Allergen Tests in the USA via its E-commerce website www.TestsforHIV.com that will debut shortly. These business opportunities are expected to provide Vencor with immediate revenues and expand its international healthcare products and services offerings.
About Vencor International
Vencor International is a global manufacturer and distributor of molecular diagnostics technologies and invitro point-of-care rapid diagnostic tests that identify diseases. Vencor distributes the AccuDx line of products including the AccuSpot(TM) Dengue Fever-IgG & IgM Rapid Test, AccuDx' DxStrip HIV Rapid Test, DxStrip Malaria Combo Rapid Test and others. www.vencorinternational.com
Safe Harbor Statement: The information contained in this press release, including any "forward-looking statements" within Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 contained herein, should be reviewed in conjunction with the company's annual report, financial filings and other publicly available information regarding the company, copies of which are available from the company upon request. Such publicly available information sets forth many risks and uncertainties related to the Companies business and such statements, including risks and uncertainties related to that, are unpredictable and outside of the influence and/or control of the company.
Vencor International, Inc. Dan Ardiel, 310-289-3488 (investor relations) email@example.com